Drug Shortage Report for MAR-RANITIDINE
| Report ID | 94581 |
| Drug Identification Number | 02443708 |
| Brand name | MAR-RANITIDINE |
| Common or Proper name | RANITIDINE |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 TABLET |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-09-16 |
| Actual start date | 2019-09-16 |
| Estimated end date | 2020-05-19 |
| Actual end date | 2020-05-19 |
| Shortage status | Resolved |
| Updated date | 2020-05-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-05-20 | English | Compare |
| v4 | 2020-05-19 | French | Compare |
| v3 | 2020-05-19 | English | Compare |
| v2 | 2019-09-24 | French | Compare |
| v1 | 2019-09-24 | English | Compare |
Showing 1 to 5 of 5